IFNA17 and HIV infectious disease: However, once latency was established, only IFNα, no other type I IFNs, efficiently reversed latency in both the in vitro model and CD4+ T cells from people living with HIV (PLWH) on suppressive ART, indicating diverse roles of type I IFNs at different stages of HIV infection [63].